Powder: -20°C for 3 years | In solvent: -80°C for 1 year
N,N'-Dinitrosopiperazine (1,4-Dinitrosopiperazine; DNP) is a carcinogen targeting nasopharyngeal epithelium that promotes nasopharyngeal carcinoma (NPC) metastasis. It modulates various signaling pathways via protein phosphorylation, notably phosphorylating LYRIC at serine 568 [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | N,N'-Dinitrosopiperazine (1,4-Dinitrosopiperazine; DNP) is a carcinogen targeting nasopharyngeal epithelium that promotes nasopharyngeal carcinoma (NPC) metastasis. It modulates various signaling pathways via protein phosphorylation, notably phosphorylating LYRIC at serine 568 [1]. |
In vitro | N,N'-Dinitrosopiperazine (referred to herein as 0.) exhibits specific activity within chemical processes by engaging in reactions characteristic to its molecular structure. |
In vivo | N,N'-Dinitrosopiperazine (administered via tail vein injection; 40 mg/kg; 30 days) suppresses cell motility and invasion while promoting nasopharyngeal carcinoma (NPC) metastasis in vivo. Immunohistochemistry (IHC) reveals that phospho-LYRIC levels are elevated in the metastatic tumors of DNP-treated mice compared to untreated controls [1]. |
Synonyms | 1,4-Dinitrosopiperazine, DNP |
Molecular Weight | 144.13 |
Formula | C4H8N4O2 |
CAS No. | 140-79-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
N,N'-Dinitrosopiperazine 140-79-4 1,4-Dinitrosopiperazine DNP inhibitor inhibit